Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement

Eric A. Deckers, Marieke W. J. Louwman, Schelto Kruijff, Harald J. Hoekstra*

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    7 Citations (Scopus)
    108 Downloads (Pure)

    Abstract

    Aim: To investigate implementation of the seventh American Joint Committee on Cancer melanoma staging with sentinel lymph node biopsy (SLNB) and associations with socioeconomic status (SES). Patients & methods: Data from The Netherlands Cancer Registry on patient and tumor characteristics were analyzed for all stage IB-II melanoma cases diagnosed 2010-2016, along with SES data from The Netherlands Institute for Social Research. Results: The proportion of SLNB-staged patients increased from 40% to 65% (p <0.001). Multivariate analysis showed that being female, elderly, or having head-and-neck disease reduced the likelihood of SLNB staging. Conclusion: SLNB staging increased by 25% during the study period but lagged among elderly patients and those with head-and-neck melanoma. In The Netherlands, SES no longer affects SLNB staging performance.

    Original languageEnglish
    Pages (from-to)27-38
    Number of pages12
    JournalMelanoma management
    Volume7
    Issue number1
    DOIs
    Publication statusPublished - May-2020

    Keywords

    • elderly
    • head and neck
    • melanoma
    • sentinel lymph node
    • socioeconomic status
    • staging
    • POPULATION-BASED ANALYSIS
    • QUALITY-OF-LIFE
    • CUTANEOUS MELANOMA
    • FOLLOW-UP
    • BIOPSY
    • MORBIDITY
    • DISSECTION
    • TRIAL
    • LYMPHADENECTOMY
    • AXILLARY

    Fingerprint

    Dive into the research topics of 'Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement'. Together they form a unique fingerprint.

    Cite this